Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that targets CD3 on T cells and MUC17 on tumor cells, promoting targeted tumor cell destruction and stimulating T cell activation and proliferation [1].
CAS Number:
[2413453-53-7]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted